Press Room

Angelo Filosa of PerkinElmer OneSource explains how working with a relocation service provider can minimize disruptions to daily operations and ensure a successful lab move.

In this article, Dr. Marc Pollmann, EUROIMMUN biologist, outlines the factors that play into accurate identification, diagnosis and treatment of tickborne illnesses like Lyme disease.

PerkinElmer and FDNA have partnered to offer genomic services paired with next-generation phenotyping technologies. The new service combines PerkinElmer Genomics' Ordered Data Interpretation Network (ODIN) software platform with FDNA's Face2Gene facial analysis technology.

Today more than half of all US citizens -- and people from 44 other countries -- have access to legal medical cannabis. As this market continues to grow and becomes more mainstream, calls for regulation and the need for the cannabis industry to ensure patient and consumer safety will similarly increase.

Prahlad Singh, president and chief operating officer, shares an update on PerkinElmer's new office facility in Singapore and growing customer base throughout Southeast Asia.

PerkinElmer is supporting the launch of Parent Project Muscular Dystrophy's (PPMD) pilot program to screen newborns in New York state for Duchenne—one of the most common forms of muscular dystrophy.

Researchers are looking for ways to more easily and effectively access, analyze and spotlight scientific data that is growing in volume and complexity and often dispersed across hard-to-access silos.

PerkinElmer will integrate its big data technology and content into Accenture's cloud-based platform, designed to drive wider efforts in drug discovery and research.

PerkinElmer was recognized as a leader in the scientific instrument industry at the 13th China Scientific Instrument Annual Conference.

As part of our mission to innovate for a healthier world, PerkinElmer is providing laboratories with the analytical tools needed to ensure safe, high-quality and compliant cannabis products.

PerkinElmer will relocate its Canadian demonstration lab to Velocity Garage, giving entrepreneurs and scientists access to the company's lab instruments, software and experts.

GenePrism: Actionable Insights is a new physician-ordered test that analyzes all 59 "medically actionable" genes identified by the American College of Medical Genetics and Genomics.

The Environmental Working Group published its annual “Dirty Dozen” list, which ranks fruits and vegetables by most and least contaminated with pesticide residues. Greg Sears, PerkinElmer’s VP and GM of Chromatography, Mass Spectrometry and Food, weighs in on why pesticide analysis is a critical part of today’s food ecosystem.

Gary Harton, a member of the team focused on pre-implantation genetic testing at PerkinElmer, talks about the process for patients who undergo genetic testing for neurodegenerative diseases.